Evidence map›Paper›PMID 34471489›Full record

ArticleComputational and structural biotechnology journal2021

ARMT: An automatic RNA-seq data mining tool based on comprehensive and integrative analysis in cancer research.

Guanda Huang, Haibo Zhang, Yimo Qu, Kaitang Huang, Xiaocheng Gong, Jinfen Wei, Hongli Du

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Guanda HuangSchool of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China.
Haibo ZhangSchool of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China.
Yimo QuSchool of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China.
Kaitang HuangSchool of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China.
Xiaocheng GongSchool of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China.
Jinfen WeiSchool of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China.
Hongli DuSchool of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The comprehensive and integrative analysis of RNA-seq data, in different molecular layers from diverse samples, holds promise to address the full-scale complexity of biological systems. Recent advances in gene set variant analysis (GSVA) are providing exciting opportunities for revealing the specific biological processes of cancer samples. However, it is still urgently needed to develop a tool, which combines GSVA and different molecular characteristic analysis, as well as prognostic characteristics of cancer patients to reveal the biological processes of disease comprehensively. Here, we develop ARMT, an automatic tool for RNA-Seq data analysis. ARMT is an efficient and integrative tool with user-friendly interface to analyze related molecular characters of single gene and gene set comprehensively based on transcriptome and genomic data, which builds the bridge for deeper information between genes and pathways, to further accelerate scientific findings. ARMT can be installed easily from https://github.com/Dulab2020/ARMT.

Indexed as

Downstream analysisGSVAIntegration R packageRNA-seq

Identifiers

PMID34471489
PMCPMC8379379

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.